THC shows promise in fighting tooth decay-causing bacteria

In Vitro Antimicrobial Effect of Tetrahydrocannabinol on Streptococcus mutans and Its Anticariogenic Potential.

International dental journal • • Moderately Relevant
🤖

AI Summary

In a groundbreaking laboratory study, researchers explored the potential antimicrobial properties of tetrahydrocannabinol (THC) against Streptococcus mutans, a primary bacteria responsible for dental cavities. The research revealed significant antibacterial effects at low concentrations, demonstrating THC's ability to interfere with bacterial growth and biofilm formation in oral environments.

The study found that THC concentrations as low as 2 μg/mL could inhibit over 90% of bacterial biofilm formation and reduce the bacteria's acid production. Interestingly, the cannabinoid demonstrated a unique mechanism of action by promoting membrane hyperpolarization in S. mutans, which may contribute to its antimicrobial properties. While THC did not completely destroy existing bacterial biofilms, it significantly reduced their metabolic activity and viability, suggesting potential applications in oral health management.

These findings open up exciting possibilities for understanding how cannabinoids might interact with oral microbiota. The research provides preliminary evidence that THC could potentially be developed into a novel anticariogenic agent, offering a novel approach to dental health that goes beyond traditional antimicrobial treatments. However, more research is needed to translate these in vitro results into practical dental care solutions.

📄 Original Abstract

With the increasing use of marijuana, it is vital to understand the effect of tetrahydrocannabinol (THC) on oral microbiota, especially the primary carious pathogen Streptococcus mutans. The minimum inhibitory concentration (MIC) of THC against S mutans was determined by antimicrobial susceptibility testing. Bacterial acid production was evaluated. The effect of THC on S mutans biofilm formation and preformed biofilms was determined by crystal violet assay. The metabolic activity and viability of the biofilm were assessed using the methylthiazolyldiphenyl tetrazolium bromide assay and live/dead assay, respectively. Extracellular polysaccharide (EPS) was examined by Cascade Blue Dextran staining. S mutans membrane potential was detected by the Baclight Bacterial Membrane Potential Kit. The MIC of THC against S mutans was 2 µg/mL (P < .0001). A total of ≥2 µg/mL THC reduced bacterial acidogenicity and inhibited over 90% of biofilm formation (P < .0001). Additionally, ≥1 µg/mL THC reduced biofilm viability and EPS production (P < .0001), as assessed by fluorescence measurements and microscopy. While 1 to 64 µg/mL THC did not degrade preformed biofilm, metabolic activity was reduced by 16 to 64 µg/mL THC (P < .01), and 8 to 32 µg/mL THC reduced biofilm viability in a time- and dose-dependent manner (P < .001). Moreover, 2 to 8 µg/mL THC promoted membrane hyperpolarization after a 5-minute treatment (P < .01). THC inhibits S mutans growth and biofilm formation while also reducing bacterial viability, EPS production, and acid production. Although it does not degrade preformed biofilm biomass, THC diminishes its metabolic activity and viability. These effects may be linked to THC-induced membrane hyperpolarization. This in vitro study suggests that THC may reduce the cariogenic capacity of S mutans. This study shows that THC inhibits S mutans growth, biofilm formation, properties of preformed biofilms, and acid production. It provides preliminary scientific evidence on the impact of THC on oral health, specifically cannabinoid consumption on cariogenesis, and a potential new avenue for developing a new anticariogenic agent.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.